Canopy Growth: Analysts Anticipate Q1 Revenues Of $149 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal first quarter financials before market open on August 6.

Analysts have a consensus C$31.97 12-month price target on the company, via a total of 15 analysts, with one analyst having a strong buy rating, and three analysts have a buy rating. Nine analysts have a hold rating and two analysts have a strong sell rating. The street high comes from MKM Partners with a C$51 price target, and the lowest target comes from Bryan Garnier with a C$18 price target.

12 analysts have revenue estimates for the first quarter. The mean between all 12 is C$149.04 million; this number has been revised slightly downwards from C$175.35 million at the start of the year. The street high is C$163.70 million while the lowest sits at C$115.43 million.

Five analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 25%, with this number being revised slightly downwards from 30.67% at the start of the year. Street high goes to Stifel-GMP with a 28% estimate and the lowest sits at 20%.

Onto EBITDA estimates, there are currently 13 analysts who have first quarter EBITDA estimates. The mean is currently (C$64.51) million, with this number being lower at the start of the year. Street high goes to Oppenheimer with a (C$45) million EBITDA estimate and the lowest being a (C$83) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Green Thumb Sees Six Analysts Up Price Targets Following Q2 Earnings

Green Thumb Industries (CSE: GTII) reported their second-quarter results last week, with the company generating...

Monday, August 17, 2020, 10:35:48 AM

US Cannabis: Stifel Expects “Limited To No Sales Growth”

Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the...

Monday, August 1, 2022, 01:17:00 PM

Canopy Growth Divests Stake in AusCann Group Holdings

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) has disposed of its 13.2% stake in AusCann...

Sunday, October 13, 2019, 10:45:16 PM

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM

Aurora Cannabis: Canaccord Cuts Price Target, Lowers 2022 Estimates

On September 27, Aurora Cannabis (TSX: ACB) reported its fiscal fourth quarter results. The companies...

Wednesday, September 29, 2021, 09:42:00 AM